FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1368431000168106: bemotrizinol 10 mg / 1 g + butyl methoxydibenzoylmethane 21 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 20 mg / 1 g + isoamyl methoxycinnamate 40 mg / 1 g + oxybenzone 21 mg / 1 g ointment (medicinal product unit of use)

Status: current, Defined. Date: 31-Aug 2019. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4161651000168112 bemotrizinol 10 mg / 1 g + butyl methoxydibenzoylmethane 21 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 20 mg / 1 g + isoamyl methoxycinnamate 40 mg / 1 g + oxybenzone 21 mg / 1 g ointment (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4161661000168114 bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment Is a bemotrizinol + butyl methoxydibenzoylmethane + isoamyl methoxycinnamate + oxybenzone + diethylamino hydroxybenzoyl hexyl benzoate true Inferred relationship Some
bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment Is a medicinal product unit of use true Inferred relationship Some
bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment has manufactured dose form ointment true Inferred relationship Some
bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment has unit of use continuous true Inferred relationship Some 1693313553
bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment has Australian BoSS oxybenzone true Inferred relationship Some 401706964
bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment has intended active ingredient oxybenzone true Inferred relationship Some 401706964
bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment has intended active ingredient diethylamino hydroxybenzoyl hexyl benzoate true Inferred relationship Some 227490248
bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment has Australian BoSS diethylamino hydroxybenzoyl hexyl benzoate true Inferred relationship Some 227490248
bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment has Australian BoSS isoamyl methoxycinnamate true Inferred relationship Some 1693313552
bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment has intended active ingredient isoamyl methoxycinnamate true Inferred relationship Some 1693313552
bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment has Australian BoSS bemotrizinol true Inferred relationship Some 480288872
bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment has intended active ingredient bemotrizinol true Inferred relationship Some 480288872
bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment has intended active ingredient butyl methoxydibenzoylmethane true Inferred relationship Some 1444948066
bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment has Australian BoSS butyl methoxydibenzoylmethane true Inferred relationship Some 1444948066
Inbound Relationships Type Active Source Characteristic Refinability Group
bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment, 15 g has MPUU True bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment Inferred relationship Some 1
Viraprox Lip Balm ointment Is a True bemotrizinol 1% + butyl methoxydibenzoylmethane 2.1% + isoamyl methoxycinnamate 4% + oxybenzone 2.1% + diethylamino hydroxybenzoyl hexyl benzoate 2% ointment Inferred relationship Some

Reference Sets

List of Excluded Medicinal Items reference set

Medicinal product unit of use reference set

Back to Start